Why Aurora Cannabis Hasn’t Signed a Deal With a U.S. Giant Like Other Pot Companies
Aurora’s Cam Battley says adviser Nelson Peltz strongly influenced the decision to remain independent.
Aurora Cannabis Inc. is one of only two major Canadian cannabis companies with a market value of more than $1.5 billion that has yet to ink a partnership or investment deal with a major U.S. company, but that’s because a rich American advised executives not to do it.
Canopy Growth Corp. CGC, -0.06% WEED, +0.94% paved the way for such deals, signing an agreement with Constellation Brands Inc. STZ, +1.09% , which ultimately invested $4 billion in the Smiths Falls, Ontario, weed producer. Much smaller rival Hexo Corp. HEXO, -0.78% HEXO, +3.29% has signed a joint venture with Molson Coors Brewing Co. TAP, +2.42% , while Cronos Group Inc. CRON, -1.63% CRON, -0.98% opted to take a $1.8 billion investment from Big Tobacco in the form of Marlboro-maker Altria Group Inc. MO, +0.19% . Privateer Holdings-backed Tilray Inc. TLRY, -0.02% is the only other highly valued pot company that has not sold pieces of its business to large, established American companies, but it did make partnership arrangements with Big Pharma and a beverage company.
– Read the entire article at Market Watch.